1. Introduction
The supramolecular organic frameworks (SOFs), also known the multi-component crystalline solids/phases or multi-component molecular crystals are the group of materials fabricated using the supramolecular crystal engineering [
1]. The supramolecular conglomerates are formed as a result of spontaneous intermolecular self-assembling achieved by creating various bunch of non-covalent interactions between the favorable functional groups that build up the molecules of organic co-partners [
2]. The occurrence of the different non-covalent contacts, embracing the classical and nonclassical H-bonds, electrostatic forces,
π···
π stacking,
π-cation and
π-anion, lone pair-
π attractions and the other ones, is necessary factor to direct the molecular arrangement in the crystals [
3]. The process of intermolecular association based on the development of combination of classical H-bonds and complementary weak non-covalent forces is responsible for fabrication of the specific crystal structures bearing particular physicochemical properties [
4].
The carboxylic acids and basic N-heterocyclic derivatives are very often employed in crystal engineering as effective building tectons in the production of new supramolecular organic frameworks (SOFs). Their leader position as building bricks in the process of engendering the multi-component organic crystalline phases is dictated by their chemical composition characterized by bearing an excellent donor and acceptor moieties susceptible to effective organic acidic-basic supramolecular complexation. The most important functional group of organic acids, that strongly interacts with other organic partners with basic nature, is –COOH group. The acidic-basic supramolecular aggregation is carried out by the facilitated formation of the neutral N–H···O/O–H···N or charged-assisted N
+–H···O
- and N–H···O
- H-bonds enclosed between pyrimidine/amine groups equipped with the lone electron pair localized on the nitrogen atoms of base ingredients and complementary caroboxylic/carboxylate groups derived from acidic co-formers. These neutral or charged-assisted strong H-bonds, holding the acidic and basic components together, influence the crystalline form of the resulting multi-component molecular materials in the co-crystal/salt category. An introduction of the extra potential binding spacers (CH, CH
2, CH
3, aryl core, halogens, OH, S, O, SO
2, NO
2) into the chemical structure of implemented co-partners yielded the more complicated networks of non-covalent forces that ultimately causes changes in the crystal packing as well as features of supramolecular solids [
5,
6,
7].
A literature survey unveiled the aminopirymidine compounds have been filed to supramolecular complexation with large number of carboxylic acids. The selected aminopyrimidines in the form of 2-aminopyrimidine (2-AP), 5-aminoaminopyrimidine (5-AP), 2-amino-4,6-dimethylpyrimidine (2-A-4,6-DMP) and 2,4,6-triaminopyrimidine (2,4,6-TAP) (
Figure 1) fit perfectly into generating the non-covalent bonding with various acidic derivatives due to the presence of three or five basic nitrogen sites.
The CSD analysis [
8] based on the
ConQuest 2022.3.0 software [
9] showed that the 2-AP and 2-A-4,6-DMP interact most readily with carboxylic co-partners giving the 64 and 58 multi-component molecular crystals, respectively (
Figure 2A). The 2,4,6-TAP specie were enclosed only in the 19 supramolecular architectures, whereas no data regarding the utility of 5-AP as a building brick in the supramolecular complexation were found (
Figure 2A). The 2-AP as well as 2-A-4,6-DMP remain in their neutral figure in the majority of disclosed crystal structures obtained with the participation of carboxylic co-formers, which constitute the 64.1 % and 67.2 % of total number of acid:base supramolecules, respectively. The structural results published in the CSD database [
8,
9] and gathered in
Figure 2B indicate that solely the 2-A-4,6-DMP entity builds the supramolecular complexes within all specified subclasses of multi-component crystalline phases [
10].
The supramolecular conglomerates fabricated from 2-AP and carboxylic co-partners generate two- or three-component molecular crystals belonging to almost all defined subclasses of SOFs [
10], except the salt co-crystal solvate (
Figure 2B). The 2-AP generally forms supramolecular adducts without any solvent as evidenced by only six reported acid:base crystalline solids containing solvent residues in the form of water (CSD refcode: NAXSIQ [
11], PUDGRUF [
12]/PUDGRUF01 [
13], SUYQAF [
14], VEVNEQ [
15]), ethanol (CSD refcode: AJECIB [
16]) or nitrobenzene (CSD refcode: KAHMOV [
17]). Interestingly, the supramolecular associations proceeding between 2-AP and benzoic acid resulted in the production of three co-crystal polymorphs described by
Pnma (CSD refcode: NUKWEW [
18] and NUKWEW01 [
18]) and
P2
1/n (NUKWOG [
18]) symmetry. The conformational discrepancies observed within the group of free dichloro-substituted phenoxyacetic acid derivatives influenced into the crystal packing generated for their supramolecular adducts with 2-AP [
19,
20]. Inclusion of the specific isomer of dichloro-substituted phenoxyacetic derivatives caused different spatial arrangement of the structural residues included into the multi-component molecular crystals, namely
P-1 (CSD refcode: LEWRIO [
19]),
P2
1/n (CSD refcode: LEWREK [
19]),
P2
1/c (CSD refcode: RADGEJ [
20]) and
Pbcn (RADFEI [
20]) for 3,4-, 2,4-, 2,3- and 2,6-dichlorophenoxyacetic units, respectively.
The greatest structural diversity of 2-A-4,6-DMP (
Figure 2B) based supramolecular associations is demonstrated in relation to p-xylylene-bis(thioacetic) acid resulting in orthorhombic
Cmca (CSD refcode: BOQNUS [
21]) and monoclinic
P2
1/c (CSD refcode: BOQNIG [21) true co-crystals as well as monoclinic
P2
1/c (CSD refcode: BOQNOM [21) co-crystal monohydrate containing only the neutral N–H···O and O–H···N H-bonds. The 2-A-4,6-DMP is characterized by the most flexible behavior towards carboxylic acids, so that as many as four-component crystalline solids are created. The 2-A-4,6-DMP and carboxylic co-formers present in the crystal lattices of the produced four-component supramolecules adopt the different residue type. The four-component co-crystal solvate formed between 2-A-4,6-DMP and ferulic acid (CSD refcode: JACCIC [
22]) with participation of acridine and acetonitrile as solvent contains all four structural units in their starting neutral figure. In the asymmetric unit of the other four-component crystal generated from 2-A-4,6-DMP and 2-hydroxy-6-napthoic acid (CSD refcode: VAJQAB [
23]) besides one water molecule, the 2-A-4,6-DMP
+ monocation as well as both the monoanionic and neutral form of 2-hydroxy-6-napthoic acid specie is also observed. The reverse content of acidic:basic residues, found in the molecular structure of four-component solid fabricated from 2-A-4,6-DMP and 5-aminoisophthalic acid (CSD refcode: POVXEG [
24]), existed as the salt co-crystal hemihydrate which consists of a half of water molecule, one monoanion of acidic component as well as both the monocationic and neutral form of basic ingredient.
In 73,7 % of the published cases (
Figure 2B), 2,4,6-triaminopyrimidine agent interact with carboxylic co-formers mostly by accepting the acidic proton by N-heterocyclic nitrogen atom and became the 2,4,6-TAP
+ cation. The 2,4,6-TAP
+ residues in these crystals are always sustained with complementary carboxylates via the charged-assisted N
+–H···O
- and multiple N–H···O
- H-bonds giving the supramolecular conglomerates in the form of salt solvates/hydrates (CSD refcode: CALVES [
8,
9], EPUQAK [
25], KEVLUV [
26], VEXQEX [
27], VEXQOH [
27], VEXQUN [
27], VEQZOQ [
27], VEXZUW [
27] and VEYBAF [
27]) and true salts (CSD refcode: DARMIV [
28], TESRAM [
29], VEYBEJ [
27], VIPZUS [
8,
9] and YUKVAE [
30]). The 2,4,6-TAP also interacts with the acidic components only by the neutral O–H···N/N–H···O H-bonds confirming the lack of proton transfer from the carboxylic species to 2,4,6-TAP entity (
Figure 2B). The neutral H-bonds were observed in several 2,4,6-TAP:carboxylic SOFs appearing in the form of true co-crystal (CSD refcode: SOVNIA [
31]) or co-crystal solvates/hydrates (CSD refcode: SOVLAQ [
31], SOVMOF [
31], SOVQAV [
31], SOVQEZ [
31]).
The acidic HBTA component, namely (benzylthio)acetic acid [
32], owing to its chemical structure (
Figure 1) containing –COOH group, organic sulphide –S– unit, –CH
2– spacers as well as aryl core seems to be excellent under non-covalent contacts. So far, HBTA was exploited only in the construction of five supramolecular conglomerates (
Figure 2A) with proline compounds (CSD refcode: XITMEW [
33], XITMIA [
33] and XITMOG [
33]) isonicotinamide (CSD refcode: XITMUM [
33]) as well as tryptamine (CSD refcode: XITNAT [
33]). The designated X-ray crystal structures of HBTA based supramolecular frameworks show that the acidic ingredient takes either a neutral or monoanion form (
Figure 2B).
This paper is devoted to successful supramolecular self-assembly explained by the non-covalent interactions formed between the (benzylthio)acetic acid and the selected aminopyrimidines, such as 2-aminopyrimidine, 5-aminopyrimidine, 2-amino-4,6- dimethylpyrimidine and 2,4,6-triaminopyrimidine, carried out through solution co-crystallization. This work also aims to characterize the generated organic complexes in the structural and supramolecular aspects utilizing the SC X-ray crystallography as well as to determine their spectral and thermal behavior applying the FT-IR spectroscopy and thermal analysis as well. Moreover, the incorporation of 5-aminopyrimidine co-former into the process of supramolecular association with HBTA contributed to obtaining the 5-AP:carboxylic multi-component crystalline phase for the first time.
2. Materials and Methods
The co-formers and solvents used in co-crystallization experiments were commercial products without further purification. (Benzylthio)acetic acid (purity 97 %) was sourced from Sigma-Aldrich. 2-Aminopyrimidine and 5-aminopyrimidine of analytical grade were purchased from Fluorochem Ltd.. 2-Amino-4,6-dimethylpyrimidine (purity 98%) was received from Alfa Aesar GmbH, whereas 2,4,6-triaminopyrimidine (purity 97 %) was procured from Acros Organics B.V.B.A.. The short-chained alcohols (methanol and ethanol) were provided by Avantor Performance Materials Poland S.A. (formerly POCH S.A.).
2.1. Single crystal preparation by solution co-crystallization
The crystals of novel multi-component molecular materials 1-4 were afforded under solution co-crystallization based on slow solvent evaporative method at ambient conditions. The well-shaped single crystals of new supramolecular complexes were successfully harvested in co-crystallization trials, in which the equimolar amounts of particular acidic and basic co-formers were combined with each other and methanol or ethanol was applied as a solvent.
All SOFs were synthesized according to the same general procedure: a methanol or ethanol solution (5 ml) of HBTA (0.182 g, 1 mmol) was combined with the methanol or ethanol solution containing dissolved 1 mmol of individual N-containing specie (0.095 g of 2-AP and 5-AP, 0.123 g 2-A-4,6-DMP or 0.125 g of 2,4,6-TAP) and stirred for 5 min. The resulting mixtures were then left undisturbed to evaporated naturally at ambient temperature. Then, after several days, the well-shaped single crystals suitable for SC XRD analysis, were harvested. The physical parameters of grown single crystals, like colour, shape and crystal size, are gathered in
Table 1.
Adduct [2-AP·HBTA] (1)
Yield for 1: 0.251 g (90.61 %); Elemental analysis results for [C4H5N3·C9H10O2S] (MW: 277.34 g mol-1). Calcd (%): C, 56.30; H, 5.45; N, 15.15; S, 11.56. Found (%): C, 56.61; H, 5.34; N, 15.28; S, 11.39.
Architecture [0.5(5-AP)·HBTA] (2)
Yield for 2: 0.228 g (82.31 %); Elemental analysis results for [0.5(C4H5N3)·C9H10O2S] (MW: 229.78 g mol-1). Calcd (%): C, 57.50; H, 5.48; N, 9.14; S, 13.95. Found (%): C, 57.32; H, 5.57; N, 9.31; S, 14.06.
Association [2-A-4,6-DMP·HBTA] (3)
Yield for 3: 0.285 g (93.44 %); Elemental analysis results for [C6H9N3·C9H10O2S] (MW: 305.39 g mol-1). Calcd (%): C, 58.99; H, 6.27; N, 13.76; S, 10.50. Found (%): C, 59.17; H, 6.15; N, 13.62; S, 10.74.
Assembly [2(2,4,6-TAP+)·2(BTA-)·MeOH] (4)
Yield for 4: 0.269 g (87.62 %); Elemental analysis results for [2(C4H8N5)·2(C9H9O2S)·CH4O] (MW: 646.79 g mol-1). Calcd (%): C, 50.14; H, 5.92; N, 21.66; S, 9.91. Found (%): C, 50.02; H, 5.81; N, 21.84; S, 10.08.
2.2. Single-crystal X-ray diffraction
An Oxford Diffraction Xcalibur CCD diffractometer (Oxford Diffraction Ltd., Abington, UK) equipped with graphite-monochromated MoK
α radiation source (λ = 0.71073 Å) was employed to collect the single crystal diffraction data for suitable selected crystals of complexes
1-
4. The SC XRD measurements were carried out either at low-temperature conditions (100(2) or 120(2) K) or at ambient temperature (295(2) K). The data sets were gathered using the
ω scan technique with an angular scan width of 1.0 °. The
CrysAlis Pro [
34] program was used for data acquisition, cell refinement, data reduction and multi-scan absorption correction. The structures were solved by direct methods with
SHELXS-86 [
35] and refined on
F2 by full-matrix least-squares techniques with
SHELXL-2018/3 [
36] both implemented in
WinGX 2021.1 [
37] software. Non-hydrogen atoms were refined with anisotropic displacement parameters. Hydrogen atoms were positioned geometrically (for carbon atoms) and were located from the different Fourier map (for oxygen and nitrogen heteroatoms) and refined as riding atoms with isotropic displacement parameters. The molecular and crystal structures graphics were presented owing to The
Mercury 2022.3.0 program [
38].
CCDC 2304064–2304067 contains the supplementary crystallographic data for this paper. The summary of crystal data, experimental details and refinement results of structures in question are summarized in
Table 1, whereas the geometry of intermolecular interactions existing in the crystals
1-
4 are shown in
Table 2.
Table 1.
Summary of X-ray crystallographic data for co-crystals 1-3 and salt solvate 4.
Table 1.
Summary of X-ray crystallographic data for co-crystals 1-3 and salt solvate 4.
Compund |
1 [2-AP·HBTA] |
2 [0.5(5-AP)·HBTA] |
3 [2-A-4,6-DMP·HBTA] |
4 [2(2,4,6-TAP⁺)·2(BTA-)·MeOH] |
Chemical formula |
[C4H5N3·C9H10O2S] |
[C2H2.5N1.5·C9H10O2S] |
[C6H9N3·C9H10O2S] |
[2(C4H8N5⁺)·2(C9H9O2S-)·CH3OH] |
Formula weight |
277.34 |
229.78 |
305.39 |
646.79 |
T [K] |
120(2) |
100(2) |
295(2) |
120(2) |
Crystal system |
triclinic |
monoclinic |
triclinic |
triclinic |
Space group |
P-1 |
I2/a |
P-1 |
P-1 |
a [Ĺ] |
5.473(2) |
11.2873(8) |
7.3644(9) |
11.9766(12) |
b [Ĺ] |
8.720(3) |
9.1219(6) |
8.2883(10) |
12.2477(11) |
c [Ĺ] |
14.262(4) |
22.7196(17) |
13.5264(12) |
12.7081(12) |
α [°] |
83.08(3) |
90.00 |
82.748(9) |
99.661(8) |
β [°] |
82.62(3) |
103.110(7) |
87.375(9) |
111.581(9) |
γ [°] |
80.40(3) |
90.00 |
75.153(10) |
106.054(8) |
V [Ĺ3] |
662.1(4) |
2278.3(3) |
791.60(16) |
1588.2(3) |
Z |
2 |
8 |
2 |
2 |
Dcalc. [g cm-3] |
1.391 |
1.340 |
1.281 |
1.352 |
µ [mm-1] |
0.246 |
0.267 |
0.212 |
0.221 |
Crystal colour and shape |
colorles plate |
colorles plate |
colorles plate |
colorles block |
Crystal size [mm] |
0.21×0.56×0.02 |
0.23×0.55×0.05 |
0.58×0.52×0.18 |
0.11×0.20×0.31 |
θ range [°] |
2.895–27.477 |
2.902–27.485 |
2.560–27.485 |
2.582–27.484 |
F(000) |
292 |
968 |
324 |
684 |
Reflections measured unique |
5060 3040 |
8584 2607 |
6170 3637 |
13063 7280 |
Observed data [I > 2σ(I)] |
2382 |
2252 |
2317 |
4470 |
Rint
|
0.0274 |
0.0263 |
0.0324 |
0.0592 |
Completeness to θmax
|
0.999 |
0.999 |
0.999 |
0.999 |
Goodness-of-fit on F2
|
1.017 |
1.048 |
1.034 |
1.017 |
R1, wR2 [I>2σ(I)] |
0.0421, 0.0906 |
0.0313, 0.0752 |
0.0534, 0.1299 |
0.0672, 0.1158 |
R1, wR2 (all data) |
0.0621, 0.1023 |
0.0391, 0.0799 |
0.0893, 0.1528 |
0.1250, 0.1417 |
Residual density [e Å-3] |
0.289, -0.252 |
0.264, -0.271 |
0.305, -0.204 |
0.345, -0.326 |
Deposition no |
2304064 |
2304065 |
2304066 |
2304067 |
2.3. Instrumentation and measurement methodology
A Perkin Elmer 2400 Series II CHNS/O elemental analyzer (PerkinElmer Inc., Waltham, USA) operating with the CHNS mode was employed to determine the percentage contents of carbon, hydrogen, nitrogen and sulphur in adducts 1-4.
A SETSYS 16/18 (Setaram, Caluire, France) thermal apparatus registering the TG and DSC thermal curves was used to measure the thermal behavior of complexes 1-4 as well as the thermal properties of individual molecular components. Weighted samples (7.085–8.692 mg) were placed in the alumina crucibles and scanned from 30 to 800 °C. The TG/DSC measurements were conducted under the dynamic air atmosphere (at the rate of the airflow of 0.75 dm3 h−1) with a constant heating rate of 10 °C min-1.
A FT/IR-4600 (JASCO Corporation, Tokyo, Japan) Fourier-transform infrared spectrometer was utilized to receive the transmission infrared spectra of all the starting molecular ingredients and co-crystallization products as well. The spectra of the tested compounds in the region 4000–400 cm-1 were recorded as pressed disks in the KBr matrix.
4. Conclusions
Four novel aminopyrimidine based multi-component crystalline solids distinguished by phase purity were prepared with (benzylthio)acetic acid. The generated supramolecular assemblies with binary and tri-component conglomerate were characterized through by SC XRD, FT-IR and TG-DSC techniques. The organic binary adducts obtained from 2-AP, 5-AP and 2-A-4,6-DMP form the co-crystals, whereas the tri-component assembly fabricated with the help of 2,4,6-TAP gives the salt methanol solvate.
It is shown that aminopyrimidines are a great supramolecular moieties that generate crystals with different hydrogen bonding network. Because of the presence of N-atoms, all multi-component crystals contain strong N–H···O interaction: one type observed in three new co-crystals and ten types formed within the crystal structure of salt methanol solvate. This significant difference in the number of hydrogen bonds is related to the transfer of a proton between the acid molecule and 2,4,6-triaminopyrimidine. When hydrogen proton is transferred between the adjacent components it is easier to generate hydrogen bonds at the site of the proton transfer. Neutral molecules in co-crystals with 2-AP, 5-AP and 2-A-4,6-DMP are connected with mainly one type of O–H···N, N–H···O/N, C–H···O/S hydrogen bond, forming 1D ribbons or tetrameric unit. Sixteen type of interactions (N–H···O/N/S, O/C–H···S) observed in the crystal structure of salt solvate with 2,4,6-TAP cause the creation of stable 3-D structure.
On the other hand, the HBTA is a flexible structural fragment that efficiently creates the diversiform of supramolecular frameworks with stable H-bonded motif, making it a noteworthy molecular ingredient with high activity for co-crystal/salt formation.
Figure 1.
Chemical formula of selected H-bond building blocks.
Figure 1.
Chemical formula of selected H-bond building blocks.
Figure 2.
The number of reported crystal structures (A) along with the summary of crystalline forms (B) of multi-component molecular crystals containing HBTA:N-heterocycles as well as carboxylic acids:2-AP/2-A-4,6-DMP/2,4,6-TAP synthons, respectively.
Figure 2.
The number of reported crystal structures (A) along with the summary of crystalline forms (B) of multi-component molecular crystals containing HBTA:N-heterocycles as well as carboxylic acids:2-AP/2-A-4,6-DMP/2,4,6-TAP synthons, respectively.
Figure 3.
The preparation scheme for crystalline solids 1-4.
Figure 3.
The preparation scheme for crystalline solids 1-4.
Figure 4.
The molecular structure of 1 showing the atom-labelling scheme (A) and the orientation of the phenyl ring of acid molecule in respect to pyrimidine moiety (B).
Figure 4.
The molecular structure of 1 showing the atom-labelling scheme (A) and the orientation of the phenyl ring of acid molecule in respect to pyrimidine moiety (B).
Figure 5.
H-bond synthons in the crystal lattice of 1.
Figure 5.
H-bond synthons in the crystal lattice of 1.
Figure 6.
The molecular structure of 2 presenting the atom-labelling scheme (A) and the orientation of the phenyl ring of acid molecule in respect to pyrimidine moiety (B).
Figure 6.
The molecular structure of 2 presenting the atom-labelling scheme (A) and the orientation of the phenyl ring of acid molecule in respect to pyrimidine moiety (B).
Figure 7.
H-bond synthons in the crystal lattice of 2.
Figure 7.
H-bond synthons in the crystal lattice of 2.
Figure 8.
The asymmetric unit of 3 showing the atom-labelling scheme (A) and the orientation of the phenyl ring of acid molecule in respect to pyrimidine moiety (B).
Figure 8.
The asymmetric unit of 3 showing the atom-labelling scheme (A) and the orientation of the phenyl ring of acid molecule in respect to pyrimidine moiety (B).
Figure 9.
H-bond synthons in the crystal lattice of 3.
Figure 9.
H-bond synthons in the crystal lattice of 3.
Figure 10.
The asymmetric unit of 4 showing the atom-labelling scheme.
Figure 10.
The asymmetric unit of 4 showing the atom-labelling scheme.
Figure 11.
H-bond synthons in the crystal lattice of 4.
Figure 11.
H-bond synthons in the crystal lattice of 4.
Figure 12.
The TG profiles of supramolecular adducts 1-4 along with the TG curves of suitable molecular building bricks.
Figure 12.
The TG profiles of supramolecular adducts 1-4 along with the TG curves of suitable molecular building bricks.
Figure 13.
The DSC curves of supramolecular assemblies 1-4 in comparison to DSC plots of the molecular components between 30 and 350 °C.
Figure 13.
The DSC curves of supramolecular assemblies 1-4 in comparison to DSC plots of the molecular components between 30 and 350 °C.
Figure 14.
The comparison of infrared spectral traces in the range of 3600-2400 cm-1 for associations 1-4 as well as the free co-partners.
Figure 14.
The comparison of infrared spectral traces in the range of 3600-2400 cm-1 for associations 1-4 as well as the free co-partners.
Figure 15.
The FT-IR profiles for phases 1-4 in relation to the infrared plots of starting components between the region of 1800 and 1000 cm-1.
Figure 15.
The FT-IR profiles for phases 1-4 in relation to the infrared plots of starting components between the region of 1800 and 1000 cm-1.
Table 2.
Hydrogen-bond parameters of co-crystals 1-3 and salt solvate 4.
Table 2.
Hydrogen-bond parameters of co-crystals 1-3 and salt solvate 4.
D–H···A* |
D–H [Å] |
H···A [Å] |
D···A [Å] |
D–H···A [°] |
*Symmetry code for A |
[2-AP·HBTA] (1) |
O2–H1O2···N1 |
0.96(3) |
1.65(3) |
2.595(2) |
169(3) |
x, y+1, z
|
N3–H1N3···O1 |
0.91(2) |
2.09(3) |
2.978(2) |
167(2) |
x, y-1, z
|
N3–H2N3···N2 |
0.82(2) |
2.27(2) |
3.090(3) |
176(2) |
-x-1, -y+1, -z+1 |
C13–H13···O2 |
0.93 |
2.66 |
3.531(3) |
157.1 |
-x+1, -y+1, -z+1 |
[0.5(5-AP)·HBTA] (2) |
O1–H1O1···N1 |
0.90(2) |
1.74(2) |
2.6361(14) |
176(2) |
x, y-1, z
|
N2–H1N2···O2 |
0.847(16) |
2.268(17) |
3.0225(16) |
148.6(15) |
|
C10–H10···O2 |
0.93 |
2.56 |
3.2693(17) |
133.1 |
x, y+1, z
|
C10–H10···O2 |
0.93 |
2.56 |
3.2693(17) |
133.1 |
-x+3/2, y+1, -z
|
C11–H11···S1 |
0.93 |
2.84 |
3.7208(13) |
158.5 |
|
[2-A-4,6-DMP·HBTA] (3) |
O2–H1O2···N1 |
1.01(3) |
1.64(3) |
2.645(2) |
170(3) |
|
N3–H1N3···O1 |
0.81(2) |
2.11(3) |
2.916(3) |
172(2) |
|
N3–H2N3···N2 |
0.83(2) |
2.20(2) |
3.036(3) |
177(2) |
- x-1, -y+2, -z+1 |
C3–H3A···O2 |
0.97 |
2.54 |
3.249(3) |
129.5 |
|
[2(2,4,6-TAP+)·2(BTA-)·MeOH] (4) |
N2–H1N2···O4 |
0.95(3) |
1.74(4) |
2.684(3) |
176(3) |
-x-1, -y+1, -z
|
N7–H1N7···O2 |
0.93(4) |
1.80(4) |
2.724(3) |
173(3) |
-x-1, -y, -z
|
N3–H2N3···O2 |
0.90(3) |
2.24(3) |
3.028(3) |
146(2) |
x-1, y, z
|
N4–H1N4···O3 |
0.85(4) |
1.99(4) |
2.842(4) |
179(3) |
-x-1, -y+1, -z
|
N4–H2N4···O1 |
0.83(3) |
2.10(3) |
2.906(4) |
164(3) |
|
N5–H2N5···O2 |
0.94(3) |
2.03(4) |
2.921(3) |
158(3) |
-x, -y, -z+1 |
N8–H1N8···O4 |
0.89(4) |
2.07(4) |
2.957(3) |
176(3) |
-x-1, -y+1, -z
|
N8–H2N8···O1 |
0.95(3) |
1.91(3) |
2.853(4) |
169(3) |
-x-1, -y, -z
|
N9–H2N9···O3 |
0.85(4) |
2.03(4) |
2.877(3) |
173(4) |
-x-2, -y+1, -z
|
N3–H1N3···N6 |
0.82(4) |
2.23(4) |
2.947(4) |
146(3) |
|
N5–H1N5···N1 |
0.84(3) |
2.41(3) |
3.147(4) |
146(3) |
-x-1, -y, -z+1 |
N9–H1N9···N3 |
0.83(3) |
2.48(4) |
3.249(4) |
155(3) |
-x-2, -y, -z
|
N10–H2N10···O5 |
0.89(3) |
1.98(3) |
2.835(4) |
161(3) |
x-1, y, z
|
N5–H1N5···S2 |
0.84(3) |
2.91(3) |
3.534(3) |
133(3) |
-x-1, -y+1, -z+1 |
O5–H1O5···S1 |
0.75(5) |
2.56(5) |
3.297(3) |
165(4) |
|
C12–H12···S1 |
0.93 |
2.81 |
3.646(3) |
150.5 |
|